Vaishali Dixit

796 total citations
18 papers, 579 citations indexed

About

Vaishali Dixit is a scholar working on Oncology, Molecular Biology and Pharmacology. According to data from OpenAlex, Vaishali Dixit has authored 18 papers receiving a total of 579 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Molecular Biology and 5 papers in Pharmacology. Recurrent topics in Vaishali Dixit's work include Drug Transport and Resistance Mechanisms (5 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Advanced Breast Cancer Therapies (2 papers). Vaishali Dixit is often cited by papers focused on Drug Transport and Resistance Mechanisms (5 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Advanced Breast Cancer Therapies (2 papers). Vaishali Dixit collaborates with scholars based in United States, United Kingdom and Japan. Vaishali Dixit's co-authors include Niresh Hariparsad, Jashvant D. Unadkat, Pankaj B. Desai, Kenneth E. Thummel, Fang Li, Jan Snoeys, Helen Tsao, Ming Zheng, Ann C. Collier and Dale Whittington and has published in prestigious journals such as Blood, The Journal of Immunology and Cancer Research.

In The Last Decade

Vaishali Dixit

17 papers receiving 568 citations

Peers

Countries citing papers authored by Vaishali Dixit

Since Specialization

Citations

This map shows the geographic impact of Vaishali Dixit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vaishali Dixit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vaishali Dixit more than expected).

Fields of papers citing papers by Vaishali Dixit

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vaishali Dixit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vaishali Dixit. The network helps show where Vaishali Dixit may publish in the future.

Co-authorship network of co-authors of Vaishali Dixit

This figure shows the co-authorship network connecting the top 25 collaborators of Vaishali Dixit. A scholar is included among the top collaborators of Vaishali Dixit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vaishali Dixit. Vaishali Dixit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Title	Journal	Authors	Indexed citations
1	PBPK Modeling to Predict Clinical Drug–Drug Interaction and Impact of Hepatic Impairment for an ADC With the Payload Auristatin F‐Hydroxypropylamide	CPT Pharmacometrics & Systems Pharmacology	Niyanta Kumar, Vaishali Dixit et al.	0
2	Emerging strategies for synthesis of heterocyclic compounds enabled by titanium oxide nanoparticles as heterogeneous catalyst	Tetrahedron	Vaishali Dixit, Parveen Kumar et al.	7
3	P464: PULSE DOSING OF POTENT AND SELECTIVE HETEROBIFUNCTIONAL MDM2 DEGRADER KT-253 DRIVES TUMOR REGRESSION AND DEMONSTRATES DIFFERENTIATED PHARMACOLOGY COMPARED TO P53/MDM2 SMALL MOLECULE INHIBITORS.	HemaSphere	Stefanie S. Schalm, Yogesh K. Chutake et al.	1
4	STAT3 degraders inhibit cellular activation, cytokine production, and Th17 development, resulting in inhibition of autoimmunity in the MOG-EAE model of CNS inflammation.	The Journal of Immunology	Jeffrey Sullivan, Crystal Brown et al.	1
5	Pharmacologic Activation of STING in the Bladder Induces Potent Antitumor Immunity in Non-Muscle Invasive Murine Bladder Cancer.	PubMed	Kang Huang, Dinesh Chandra et al.	13
6	A First-in-Class STAT3 Degrader KT-333 in Development for Treatment of Hematologic Cancers	Blood	Vaishali Dixit, Michele Mayo et al.	14
7	Prediction of Transporter-Mediated Drug-Drug Interactions and Phenotyping of Hepatobiliary Transporters Involved in the Clearance of E7766, a Novel Macrocycle-Bridged Dinucleotide	Drug Metabolism and Disposition	Rongrong Jiang, Andrew Hart et al.	3
8	First-in-human study of the PARP/tankyrase inhibitor E7449 in patients with advanced solid tumours and evaluation of a novel drug-response predictor	British Journal of Cancer	Ruth Plummer, Nicola Cresti et al.	57
9	Physiologically‐Based Pharmacokinetic Modeling in Renal and Hepatic Impairment Populations: A Pharmaceutical Industry Perspective	Clinical Pharmacology & Therapeutics	Tycho Heimbach, Yuan Chen et al.	91
10	Abstract 592: Demonstration of E7766, a novel STING agonist, as a potent immunotherapy in BCG-insensitive non-muscle invasive bladder cancer models via intravesical administration	Cancer Research	Kuan‐Chun Huang, Chi Zhang et al.	7
11	Physiologically‐Based Pharmacokinetic Models for Evaluating Membrane Transporter Mediated Drug–Drug Interactions: Current Capabilities, Case Studies, Future Opportunities, and Recommendations	Clinical Pharmacology & Therapeutics	Kunal S. Taskar, Venkatesh Pilla Reddy et al.	110
12	Celecoxib is a substrate of CYP2D6: Impact on celecoxib metabolism in individuals with CYP2C9*3 variants	Drug Metabolism and Pharmacokinetics	Ming‐Hong Hao, Vaishali Dixit et al.	21
13	Abstract 3961: Role for neuropilin1 in mode of action of chlorotoxin	Cancer Research	Donna Kolber‐Simonds, Jiayi Wu et al.	1
14	Application of Micropatterned Cocultured Hepatocytes to Evaluate the Inductive Potential and Degradation Rate of Major Xenobiotic Metabolizing Enzymes	Drug Metabolism and Disposition	Vaishali Dixit, Helen Tsao et al.	38
15	Discovery and Characterization of a Water-Soluble Prodrug of a Dual Inhibitor of Bacterial DNA Gyrase and Topoisomerase IV	ACS Medicinal Chemistry Letters	Hardwin O’Dowd, Dean Shannon et al.	19
16	Epilepsy - A Comprehensive Review		Vaishali Dixit et al.	17
17	Complex Drug Interactions of HIV Protease Inhibitors 2: In Vivo Induction and In Vitro to In Vivo Correlation of Induction of Cytochrome P450 1A2, 2B6, and 2C9 by Ritonavir or Nelfinavir	Drug Metabolism and Disposition	Brian Kirby, Ann C. Collier et al.	58
18	Cytochrome P450 Enzymes and Transporters Induced by Anti-Human Immunodeficiency Virus Protease Inhibitors in Human Hepatocytes: Implications for Predicting Clinical Drug Interactions	Drug Metabolism and Disposition	Vaishali Dixit, Niresh Hariparsad et al.	121

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact